Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Cancers|April 12, 2022
Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate CancerJuan Morote, Angel Borque-Fernando, Marina Triquell, et al.International Journal of Molecular Sciences|June 19, 2013
The present and future of prostate cancer urine biomarkersMarina Rigau, Mireia Olivan, Marta Garcia, et al.Urologic Oncology|November 8, 2020
Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findingsJuan Morote, Iván Schwartzman, Angel Borque, et al.Cancers|May 28, 2022
Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate BiopsyJuan Morote, Angel Borque-Fernando, Marina Triquell, et al.Cancers|December 24, 2021
Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate SamplesMireia Olivan, Marta Garcia, Leticia Suárez, et al.The Journal of Urology|July 13, 2010
Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphismsJuan Morote, Jokin Del Amo, Angel Borque, et al.The Prostate|April 27, 2011
A three-gene panel on urine increases PSA specificity in the detection of prostate cancerMarina Rigau, Israel Ortega, Maria Carmen Mir, et al.Cancers|March 25, 2022
The Barcelona Predictive Model of Clinically Significant Prostate CancerJuan Morote, Angel Borque-Fernando, Marina Triquell, et al.BJU International|July 5, 2012
Genetic predisposition to early recurrence in clinically localized prostate cancerÁngel Borque, Jokin del Amo, Luis M Esteban, et al.BJU International|March 1, 2023
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imagingJuan Morote, Hayley Pye, Miriam Campistol, et al.Pageof 8